Charlotte’s Web Holdings, Inc. (TSX: CWEB) (OTC: CWBHF) Q4 2025 Earnings: Revenue Beats, Wider Net Loss, Major BAT Strategic Transaction
Charlotte’s Web Holdings, a notable player in the botanical wellness sector, recently reported its financial results for the fourth quarter of 2025, revealing both positive revenue growth and challenges related to net losses. As the market leader in cannabidiol (CBD) products, the company’s performance is closely watched by investors and industry analysts alike.
Q4 2025 Earnings Overview
- Revenue Beat: Charlotte’s Web reported Q4 revenue of $13.3 million, surpassing analyst expectations of approximately $12.3 million. This figure reflects a notable 4.7% year-over-year increase, signaling continued demand for its CBD and hemp-derived products.
- EPS Miss: Despite the revenue growth, the company faced a wider net loss of $11.5 million, translating to a GAAP EPS of -$0.07. This was below the consensus estimate, which anticipated a loss between – $0.03 and – $0.04.
- Strategic BAT Transaction: A significant aspect of the earnings report was the announcement of a strategic agreement with British American Tobacco (BAT). This deal involves the conversion of a C$75.3 million convertible debenture into common shares, alongside a new US$10 million equity investment.
Financial Performance Analysis
In Q4 2025, Charlotte’s Web reported net revenue of $13.3 million, which, although a positive sign, comes with the backdrop of ongoing profitability challenges. The increase from $12.7 million in Q4 2024 suggests a gradual recovery and resilience in a competitive market.
The net loss of $11.5 million illustrates the financial hurdles the company faces, with a significant increase from the $3.4 million loss in the same quarter last year. The gross profit for the quarter stood at approximately $5.0 million, while the operating loss was around $5.6 million. Furthermore, Adjusted EBITDA showed a loss of about $4.4 million, widening from previous periods, indicating that the company is still navigating financial difficulties despite some operational improvements.
Full-Year Performance
For the full year 2025, Charlotte’s Web generated revenue of $49.9 million, marking a modest increase of 0.5% compared to 2024. However, the operating loss saw improvement, narrowing to $20.3 million from $32.0 million the previous year. This reflects the company’s strategic focus on cost management and operational efficiency.
Strategic Partnership with British American Tobacco
One of the most pivotal developments during this earnings cycle was the strategic transaction with BT DE Investments Inc., a subsidiary of British American Tobacco. This agreement includes:
- Conversion of the outstanding C$75.3 million convertible debenture, along with approximately C$14.2 million in accrued interest, into common shares at a rate of C$0.94 per share.
- A concurrent new US$10 million equity investment via private placement.
This strategic partnership is expected to result in the issuance of approximately 110 million common shares to BAT, enhancing the company’s equity commitment to around US$75 million. This infusion of capital is poised to strengthen Charlotte’s Web’s balance sheet significantly, enabling the company to pursue key operational priorities, including participation in the CMMI Medicare Pilot Program.
The transaction, which is still subject to shareholder and regulatory approvals, is anticipated to bolster the company’s capital structure, facilitating a more stable operational environment moving forward.
Looking Ahead: Pathway to Profitability
Despite the losses reported, Charlotte’s Web management remains optimistic about the future. They have highlighted progress in improving the cost structure, advancing product innovation, and enhancing regulatory momentum. The company is particularly focused on building its direct-to-consumer channels, which could provide a substantial boost in revenue as consumer preferences shift towards online shopping.
With the backing of BAT and a renewed focus on profitability, Charlotte’s Web Holdings, Inc. is positioning itself to capitalize on the growing demand for CBD products in the wellness sector. As the market continues to evolve, the company’s strategic initiatives could pave the way for a brighter financial future.
